ADAP - Adaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q2 2020 Results - Earnings Call Transcript
Adaptimmune Therapeutics plc (ADAP)
Q2 2020 Earnings Conference Call
August 6, 2020, 8:00 AM ET
Company Participants
Juli Miller - Senior Director, IR
Adrian Rawcliffe - CEO
Elliot Norry - Senior VP and Chief Medical Officer
Helen Tayton-Martin - Co-Founder and Chief Business Officer
John Lunger - Chief Patient Supply Officer
Conference Call Participants
Marc Frahm - Cowen and Company
Tony Butler - ROTH Capital
Mohit Bansal - Citigroup
Kelsey Goodwin - Guggenheim Securities
Nick Abbott - Wells Fargo Securities
Jonathan Chang - SVB Leerink
Gabriel Fung - Mizuho Securities
Presentation
Operator
Hello, and welcome